TelyRx Holdings Inc. experienced a notable gain in its stock price during yesterday's trading session.
TelyRx Holdings Inc. saw its shares rise by 5.77% yesterday, closing at CA$2.75. This upward movement reflects a growing interest in the company as it continues to establish itself in the market following its recent transition to the TSX.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$73.09M
52W high
$4.25
52W low
$2.00
1W change
-3.51%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 118.2% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+118.2% Upside
Current Price
C$2.75
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
107.5%
Annualized
90-Day Vol
102.2%
Annualized
Trend (90d)
-36.5%
Annualized drift
90d Mean
C$2.41
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.63 | C$1.82 – C$3.82 |
| 60 trading days | C$2.52 | C$1.49 – C$4.26 |
| 90 trading days | C$2.41 | C$1.27 – C$4.59 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors may view TelyRx's recent performance as a positive indicator of its potential growth trajectory, especially given its recent financial results.
5.77% Gain in One Day
TelyRx's stock price increased by CA$0.15, reflecting a strong performance in yesterday's trading session.
Bull case
The recent surge in TelyRx's stock price suggests that investors are becoming more confident in the company. This comes after TelyRx reported a significant revenue increase in its latest financial results, which could indicate a promising future.
Bear case
Despite the positive movement, potential investors should stay cautious. TelyRx is still operating at a loss, and its P/E ratio is not applicable, which raises questions about its profitability.
Recent Performance Highlights
Advertisement
In yesterday's trading session, TelyRx Holdings Inc. saw its stock price climb to CA$2.75, marking a 5.77% increase. This positive movement may reflect growing investor confidence following the company's recent financial results, which showed a substantial revenue increase.
Company Background and Market Position
TelyRx Holdings Inc., which recently transitioned to the TSX, is focused on delivering innovative healthcare solutions. With a market cap of approximately CA$73 million, the company is still in its growth phase, and investors are keenly observing its developments.
Looking Ahead
As TelyRx continues to establish its market presence, investors should keep an eye on upcoming financial results and strategic announcements. The recent stock surge could be a precursor to more significant developments in the company's growth story.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
